Form 144 Filer Information UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Form 144

NOTICE OF PROPOSED SALE OF SECURITIES
PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933

Form 144

144: Issuer Information

Name of Issuer
Jounce Therapeutics, Inc.
SEC File Number
001-37998
Address of Issuer
780 MEMORIAL DRIVE
CAMBRIDGE
MASSACHUSETTS
02139
Phone
857-259-3840
Name of Person for Whose Account the Securities are To Be Sold
MURRAY RICHARD /CA/
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer
  1. Officer
  2. Director

144: Securities Information


RecordTitle of the Class of Securities To Be SoldName and Address of the BrokerNumber of Shares or Other Units To Be SoldAggregate Market ValueNumber of Shares or Other Units OutstandingApproximate Date of SaleName the Securities Exchange
#1Common Stock
Etrade Financial Corporation
3 Edison Drive
Alpharetta
GEORGIA
30005
45,000$51,300.0051,694,23701/09/2023
Nasdaq Stock Market

144: Securities To Be Sold

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

RecordTitle of the ClassDate you AcquiredNature of Acquisition TransactionName of Person from Whom AcquiredIs this a Gift?Date Donor AcquiredAmount of Securities AcquiredDate of PaymentNature of Payment *
#1Common Stock01/06/2023Vesting of restricted stock unitsIssuer☐ — 81,67001/06/2023(1)


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

144: Securities Sold During The Past 3 Months

Nothing to Report☒

144: Remarks and Signature

Remarks
(1) The securities to be sold were received upon the settlement of vested restricted stock units. Under the applicable plan and award agreement, upon vesting, restricted stock units are settled in shares of Common Stock on a 1-for-1 basis without any payment.
Date of Notice
01/06/2023
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1
  1. 09/17/2019

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature
/s/ Caroline Gammill, attorney-in-fact

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Documents

File Name:
MurrayPOA2022.txt
Conformed Form Type:
EX-24
Related Form Type:
Description:
Murray Power of Attorney
Contents:
TElNSVRFRCBQT1dFUiBPRiBBVFRPUk5FWSBGT1IgU0VDVElPTiAxNiBSRVBPUlRJTkcgT0JM SUdBVElPTlMNCktub3cgYWxsIGJ5IHRoZXNlIHByZXNlbnQsIHRoYXQgdGhlIHVuZGVyc2ln bmVkIGhlcmVieSBtYWtlcywgDQpjb25zdGl0dXRlcyBhbmQgYXBwb2ludHMgZWFjaCBvZiBL aW0gQy4gRHJhcGtpbiwgSmFjcXVlbHluIEZhaGV5IA0KU2FuZGVsbCwgRWxpemFiZXRoIFNo b3J0c2xlZXZlIGFuZCBDYXJvbGluZSBHYW1taWxsLCBzaWduaW5nIHNpbmdseSANCmFuZCBl YWNoIGFjdGluZyBpbmRpdmlkdWFsbHksIGFzIHRoZSB1bmRlcnNpZ25lZCBzIHRydWUgYW5k IGxhd2Z1bCANCmF0dG9ybmV5IGluIGZhY3Qgd2l0aCBmdWxsIHBvd2VyIGFuZCBhdXRob3Jp dHkgYXMgaGVyZWluYWZ0ZXIgZGVzY3JpYmVkDQp0bzoNCihpKSBleGVjdXRlIGZvciBhbmQg b24gYmVoYWxmIG9mIHRoZSB1bmRlcnNpZ25lZCwgaW4gdGhlIHVuZGVyc2lnbmVkJ3MNCiBj YXBhY2l0eSBhcyBhIGRpcmVjdG9yLCBvZmZpY2VyIGFuZCBvciBzdG9ja2hvbGRlciAgb2Yg DQpKb3VuY2UgVGhlcmFwZXV0aWNzLCBJbmMuICh0aGUgQ29tcGFueSksIEZvcm1zIDMsIDQs IGFuZCA1DQooaW5jbHVkaW5nIGFueSBhbWVuZG1lbnRzIHRoZXJldG8pIGluIGFjY29yZGFu Y2Ugd2l0aCANClNlY3Rpb24gMTYoYSkgb2YgdGhlIFNlY3VyaXRpZXMgRXhjaGFuZ2UgQWN0 IG9mIDE5MzQgYW5kIHRoZSBydWxlcyB0aGVyZXVuZGVyDQogKHRoZSBFeGNoYW5nZSBBY3Qp IGFuZC9vciBGb3JtcyAxNDQgKGluY2x1ZGluZyBhbnkgYW1lbmRtZW50cyB0aGVyZXRvKQ0K IGluIGFjY29yZGFuY2Ugd2l0aCBSdWxlIDE0NCAoUnVsZSAxNDQpDQogdW5kZXIgdGhlIFNl Y3VyaXRpZXMgQWN0IG9mIDE5MzMsIGFzIGFtZW5kZWQgKHRoZSBTZWN1cml0aWVzIEFjdCk7 DQooaWkpIGRvIGFuZCBwZXJmb3JtIGFueSBhbmQgYWxsIGFjdHMgZm9yIGFuZCBvbiBiZWhh bGYgb2YgdGhlIHVuZGVyc2lnbmVkIA0Kd2hpY2ggbWF5IGJlIG5lY2Vzc2FyeSBvciBkZXNp cmFibGUgdG8gcHJlcGFyZSwgY29tcGxldGUgDQphbmQgZXhlY3V0ZSBhbnkgc3VjaCBGb3Jt IDMsIDQsIG9yIDUgb3IgRm9ybSAxNDQsIHByZXBhcmUsIGNvbXBsZXRlIGFuZCBleGVjdXRl DQogYW55IGFtZW5kbWVudCBvciBhbWVuZG1lbnRzIHRoZXJldG8sIGFuZCB0aW1lbHkgZGVs aXZlciBhbmQgZmlsZSBzdWNoIGZvcm0gDQp3aXRoIHRoZSBVbml0ZWQgU3RhdGVzIFNlY3Vy aXRpZXMgYW5kIEV4Y2hhbmdlIENvbW1pc3Npb24gKHRoZSBTRUMpIGFuZCANCmFueSBzdG9j ayBleGNoYW5nZSBvciBzaW1pbGFyICBhdXRob3JpdHksIGluY2x1ZGluZyB3aXRob3V0IGxp bWl0YXRpb24gdGhlIA0KZXhlY3V0aW9uIGFuZCBmaWxpbmcgb2YgYSBGb3JtIElEIG9yIGFu eSBvdGhlciBhcHBsaWNhdGlvbiBtYXRlcmlhbHMgDQp0byBlbmFibGUgdGhlIHVuZGVyc2ln bmVkIHRvIGdhaW4gb3IgbWFpbnRhaW4gYWNjZXNzIHRvIA0KdGhlIEVsZWN0cm9uaWMgRGF0 YSBHYXRoZXJpbmcsIEFuYWx5c2lzIGFuZCBSZXRyaWV2YWwgc3lzdGVtDQogb2YgdGhlIFNF QzsNCihpaWkpIHNlZWsgb3Igb2J0YWluLCBhcyB0aGUgdW5kZXJzaWduZWQncyByZXByZXNl bnRhdGl2ZSBhbmQgb24gDQp0aGUgdW5kZXJzaWduZWQncyBiZWhhbGYsIGluZm9ybWF0aW9u IHJlZ2FyZGluZyB0cmFuc2FjdGlvbnMgaW4gDQp0aGUgQ29tcGFueSdzIHNlY3VyaXRpZXMg ZnJvbSBhbnkgdGhpcmQgcGFydHksIGluY2x1ZGluZyANCmJyb2tlcnMsIGVtcGxveWVlIGJl bmVmaXQgcGxhbiBhZG1pbmlzdHJhdG9ycyBhbmQgdHJ1c3RlZXMsIGFuZCB0aGUgDQp1bmRl cnNpZ25lZCBoZXJlYnkgYXV0aG9yaXplcyBhbnkgc3VjaCB0aGlyZCBwYXJ0eSB0byByZWxl YXNlDQphbnkgc3VjaCBpbmZvcm1hdGlvbiB0byB0aGUgaGVyZWluIGFwcG9pbnRlZCBhdHRv cm5leSBpbiBmYWN0IGFuZA0KYXBwcm92ZXMgYW5kIHJhdGlmaWVzIGFueSBzdWNoIHJlbGVh c2Ugb2YgaW5mb3JtYXRpb247IGFuZA0KKGl2KSB0YWtlIGFueSBvdGhlciBhY3Rpb24gb2Yg YW55IHR5cGUgd2hhdHNvZXZlciBpbiBjb25uZWN0aW9uIA0Kd2l0aCB0aGUgZm9yZWdvaW5n ICB3aGljaCwgaW4gdGhlIG9waW5pb24gb2Ygc3VjaCANCmF0dG9ybmV5IGluIGZhY3QsIG1h eSBiZSBvZiBiZW5lZml0IHRvLCBpbiB0aGUgYmVzdCBpbnRlcmVzdCANCm9mLCBvciBsZWdh bGx5IHJlcXVpcmVkIGJ5LCB0aGUgdW5kZXJzaWduZWQsICBpdCBiZWluZyB1bmRlcnN0b29k IA0KdGhhdCB0aGUgZG9jdW1lbnRzIGV4ZWN1dGVkIGJ5IHN1Y2ggYXR0b3JuZXkgaW4gZmFj dCBvbiBiZWhhbGYgb2YgDQp0aGUgdW5kZXJzaWduZWQgcHVyc3VhbnQgdG8gdGhpcyBQb3dl ciBvZiBBdHRvcm5leSBzaGFsbCBiZSBpbiANCnN1Y2ggZm9ybSBhbmQgc2hhbGwgY29udGFp biBzdWNoIHRlcm1zIGFuZCBjb25kaXRpb25zIGFzIA0Kc3VjaCBhdHRvcm5leSBpbiBmYWN0 IG1heSBhcHByb3ZlIGluIHN1Y2ggYXR0b3JuZXkgaW4gZmFjdCdzIGRpc2NyZXRpb24uDQoN ClRoZSB1bmRlcnNpZ25lZCBoZXJlYnkgZ3JhbnRzIHRvIGVhY2ggc3VjaCBhdHRvcm5leSBp biBmYWN0IGZ1bGwgcG93ZXIgDQphbmQgYXV0aG9yaXR5IHRvIGRvIGFuZCBwZXJmb3JtIGFu eSBhbmQgZXZlcnkgYWN0IGFuZCB0aGluZyB3aGF0c29ldmVyICANCnJlcXVpc2l0ZSwgbmVj ZXNzYXJ5LCBvciBwcm9wZXIgdG8gYmUgZG9uZSBpbiB0aGUgZXhlcmNpc2Ugb2YgYW55IG9m IA0KdGhlIHJpZ2h0cyBhbmQgcG93ZXJzIGhlcmVpbiBncmFudGVkLCANCmFzIGZ1bGx5IHRv IGFsbCBpbnRlbnRzIGFuZCBwdXJwb3NlcyBhcyB0aGUgdW5kZXJzaWduZWQgbWlnaHQgb3Ig Y291bGQgZG8gaWYgDQpwZXJzb25hbGx5IHByZXNlbnQsIHdpdGggZnVsbCBwb3dlciBvZiBz dWJzdGl0dXRpb24gb3IgcmV2b2NhdGlvbiwgaGVyZWJ5IA0KcmF0aWZ5aW5nIGFuZCBjb25m aXJtaW5nIGFsbCB0aGF0IHN1Y2ggYXR0b3JuZXkgaW4gZmFjdCwgb3Igc3VjaCBhdHRvcm5l eQ0KaW4gZmFjdCdzIHN1YnN0aXR1dGUgb3Igc3Vic3RpdHV0ZXMsIHNoYWxsIGxhd2Z1bGx5 IGRvIG9yIGNhdXNlIA0KdG8gYmUgZG9uZSBieSB2aXJ0dWUgb2YgdGhpcyBwb3dlciBvZiBh dHRvcm5leSBhbmQgdGhlIHJpZ2h0cyBhbmQgDQpwb3dlcnMgaGVyZWluIGdyYW50ZWQuDQpU aGUgdW5kZXJzaWduZWQgYWNrbm93bGVkZ2VzIHRoYXQgdGhlIGZvcmVnb2luZyBhdHRvcm5l eXMgaW4gZmFjdCwgDQppbiBzZXJ2aW5nIGluIHN1Y2ggY2FwYWNpdHkgYXQgdGhlIHJlcXVl c3Qgb2YgdGhlIHVuZGVyc2lnbmVkLCBhcmUgbm90IGFzc3VtaW5nDQpub3IgcmVsaWV2aW5n LCBub3IgaXMgdGhlIENvbXBhbnkgYXNzdW1pbmcgbm9yIHJlbGlldmluZywgYW55IG9mIHRo ZSANCnVuZGVyc2lnbmVkIHMgcmVzcG9uc2liaWxpdGllcyB0byBjb21wbHkgd2l0aCBTZWN0 aW9uIDE2IG9mIHRoZQ0KRXhjaGFuZ2UgQWN0IG9yIFJ1bGUgMTQ0IG9mIHRoZSBTZWN1cml0 aWVzIEFjdC4gDQpUaGUgdW5kZXJzaWduZWQgYWNrbm93bGVkZ2VzIHRoYXQgbmVpdGhlciB0 aGUgQ29tcGFueSANCm5vciB0aGUgZm9yZWdvaW5nIGF0dG9ybmV5cyBpbiBmYWN0IGFzc3Vt ZSAoaSkgYW55IGxpYWJpbGl0eSBmb3IgDQp0aGUgdW5kZXJzaWduZWQgcyByZXNwb25zaWJp bGl0eSB0byBjb21wbHkgd2l0aCB0aGUgcmVxdWlyZW1lbnQNCm9mIHRoZSBFeGNoYW5nZSBB Y3QsIA0KKGlpKSBhbnkgbGlhYmlsaXR5IG9mIHRoZSB1bmRlcnNpZ25lZCBmb3IgYW55IGZh aWx1cmUgdG8gY29tcGx5IHdpdGggc3VjaCANCnJlcXVpcmVtZW50cywgb3IgKGlpaSkgYW55 IG9ibGlnYXRpb24gb3IgbGlhYmlsaXR5IG9mIHRoZSB1bmRlcnNpZ25lZCANCmZvciBwcm9m aXQgZGlzZ29yZ2VtZW50IHVuZGVyIFNlY3Rpb24gMTYoYikgb2YgdGhlIEV4Y2hhbmdlIEFj dC4NClRoaXMgUG93ZXIgb2YgQXR0b3JuZXkgc2hhbGwgcmVtYWluIGluIGZ1bGwgZm9yY2Ug YW5kIGVmZmVjdCB1bnRpbCANCnRoZSB1bmRlcnNpZ25lZCBpcyBubyBsb25nZXIgcmVxdWly ZWQgdG8gZmlsZSBGb3JtcyAzLCA0LCBhbmQgb3IgRm9ybXMgMTQ0DQp3aXRoIHRoZSBTRUMg d2l0aCByZXNwZWN0IHRvIHRoZSB1bmRlcnNpZ25lZCdzIGhvbGRpbmdzIG9mIGFuZCB0cmFu c2FjdGlvbnMNCiBpbiBzZWN1cml0aWVzIGlzc3VlZCBieSB0aGUgQ29tcGFueSwgdW5sZXNz IGVhcmxpZXIgcmV2b2tlZCBieSB0aGUgdW5kZXJzaWduZWQNCmluIGEgc2lnbmVkIHdyaXRp bmcgZGVsaXZlcmVkIHRvIHRoZSBmb3JlZ29pbmcgYXR0b25yZXlzIGluIGZhY3QuDQpJTiBX SVRORVNTIFdIRVJFT0YsIHRoZSB1bmRlcnNpZ25lZCBoYXMgY2F1c2VkIHRoaXMgUG93ZXIg b2YgQXR0b3JuZXkgDQp0byBiZSBleGVjdXRlZCBhcyBvZiB0aGlzIDIzcmQgZGF5IG9mIERl Y2VtYmVyLCAyMDIyLg0KL3MvIFJpY2hhcmQgTXVycmF5DQpOYW1lOiBSaWNoYXJkIE11cnJh eQ0K

Jounce Therapeutics (NASDAQ:JNCE)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024 Plus de graphiques de la Bourse Jounce Therapeutics
Jounce Therapeutics (NASDAQ:JNCE)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024 Plus de graphiques de la Bourse Jounce Therapeutics